The PE Ratio as of November 2024 (TTM) for Kintara Therapeutics, Inc. (KTRA) is -0.02

According to Kintara Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.02. This represents a change of -99.75% compared to the average of -7.86 of the last 4 quarters.

Kintara Therapeutics, Inc. (KTRA) Historical PE Ratio (quarterly & annually)

How has KTRA PE Ratio performed in the past?

The mean historical PE Ratio of Kintara Therapeutics, Inc. over the last ten years is -81.72. The current -0.02 PE Ratio has changed -97.55% with respect to the historical average. Over the past ten years (40 quarters), KTRA's PE Ratio was at its highest in in the March 2024 quarter at -1.90. The PE Ratio was at its lowest in in the June 2015 quarter at -295.78.

Kintara Therapeutics, Inc. (KTRA) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Kintara Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Kintara Therapeutics, Inc. (KTRA) Average PE Ratio

How has KTRA PE Ratio performed in the past?

The current PE Ratio of Kintara Therapeutics, Inc. (KTRA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Kintara Therapeutics, Inc. (KTRA) PE Ratio vs. Peers

How is KTRA’s PE Ratio compared to its peers?

Kintara Therapeutics, Inc.’s PE Ratio is greater than Fresh Tracks Therapeutics, Inc. (-3.00), greater than SAB Biotherapeutics, Inc. (-0.64), greater than Theriva Biologics, Inc. (-0.05), greater than Lisata Therapeutics, Inc. (-1.16), greater than Dyadic International, Inc. (-9.00), greater than Forte Biosciences, Inc. (-0.86), greater than DiaMedica Therapeutics Inc. (-9.26), greater than Kineta, Inc. (-0.36), greater than Longboard Pharmaceuticals, Inc. (-30.52), greater than Lumos Pharma, Inc. (-1.03), less than ImmunoCellular Therapeutics, Ltd. (0), greater than Cellectar Biosciences, Inc. (-1.39), greater than Bolt Biotherapeutics, Inc. (-0.34), greater than First Wave BioPharma, Inc. (-0.85), greater than Salarius Pharmaceuticals, Inc. (-0.35), greater than Vaccinex, Inc. (-0.39), greater than GeoVax Labs, Inc. (-0.78), greater than scPharmaceuticals Inc. (-1.95), greater than Milestone Pharmaceuticals Inc. (-2.85), greater than Oncolytics Biotech Inc. (-3.67), greater than Seres Therapeutics, Inc. (-4.61), greater than aTyr Pharma, Inc. (-2.33),

Build a custom stock screener for Kintara Therapeutics, Inc. (KTRA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kintara Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Kintara Therapeutics, Inc. (KTRA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Kintara Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.